T R Baker

No ORCID on file · 1 paper in corpus
other 1992
Gynecologic Oncology ·doi:10.1016/0090-8258(92)90232-8

Thirty-two stage IC or stage I grade 3 patients with invasive ovarian adenocarcinoma were treated with 6 months of adjuvant cisplatin-based chemotherapy. With a median follow-up of 60.5 months, there have been three (9%) recurrences. The 5-…